Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aastrom BRCs for bone regeneration in sinus augmentation
NCT00980278Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Mar 2010
- Primary completion
- Jul 2013
- Modality
- Mesenchymal Stem Cells, Hematopoietic Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ixmyelocel-T in tooth loss, sponsored by University of Michigan. Started Mar 2010; status: completed.
02
Drugs
ixmyelocel-T
03
Conditions
tooth loss
Beyond the preview
Go deeper on NCT00980278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980278.